Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]latest-news-updates/to-shield-patents-firms-seek-information-on-generic-drug-launches-sushmi-dey-4686928.html"/> LATEST NEWS UPDATES | To shield patents, firms seek information on generic drug launches -Sushmi Dey | Im4change.org
Resource centre on India's rural distress
 
 

To shield patents, firms seek information on generic drug launches -Sushmi Dey

-The Times of India

NEW DELHI: In what is being seen as an attempt to delay launch of low priced generic medicines, multinational drug makers have asked the government to create a registry providing information about all drug applications pending manufacturing and marketing approval.

The proposal, if accepted by the government, will help ‘big pharma’ pre-emptively challenge generic drug makers in court for allegedly infringing upon their patents and in turn blocking or delaying the entry of the low cost version of the drug in the market. The health ministry has vehemently opposed the proposal on grounds that it will not only be “unfair to local drug manufacturers to disclose their product strategy” but also has “the potential to substantially increase healthcare costs for the public” as launch of generic products will get delayed through litigation, a senior official said. He added, such information about product applications filed for approval are not disclosed anywhere in the world.

However, the proposal is still pending with the department of pharmaceuticals (DoP) — another wing of the government that looks into pharmaceutical industry under the ministry of chemicals and fertilisers.

Please click here to read more.